Literature DB >> 27702699

Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders.

Shambhunath Bose1, Jungsook Cho2.   

Abstract

Protein misfolding, which is known to cause several serious diseases, is an emerging field that addresses multiple therapeutic areas. Misfolding of a disease-specific protein in the central nervous system ultimately results in the formation of toxic aggregates that may accumulate in the brain, leading to neuronal cell death and dysfunction, and associated clinical manifestations. A large number of neurodegenerative diseases in humans, including Alzheimer's, Parkinson's, Huntington's, and prion diseases, are primarily caused by protein misfolding and aggregation. Notably, the cellular system is equipped with a protein quality control system encompassing chaperones, ubiquitin proteasome system, and autophagy, as a defense mechanism that monitors protein folding and eliminates inappropriately folded proteins. As the intrinsic molecular mechanisms of protein misfolding become more clearly understood, the novel therapeutic approaches in this arena are gaining considerable interest. The present review will describe the chaperones network and different approaches as the therapeutic targets for neurodegenerative diseases. Current and emerging therapeutic approaches to combat neurodegenerative diseases, addressing the roles of molecular, chemical, and pharmacological chaperones, as well as heat shock factor-1 and the unfolded protein response, are also discussed in detail.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Heat shock factor-1; Molecular chaperones; Neurodegenerative disorders; Protein misfolding; Protein quality control system; Unfolded protein response

Mesh:

Substances:

Year:  2016        PMID: 27702699     DOI: 10.1016/j.arr.2016.09.004

Source DB:  PubMed          Journal:  Ageing Res Rev        ISSN: 1568-1637            Impact factor:   10.895


  18 in total

Review 1.  Causative Genes in Amyotrophic Lateral Sclerosis and Protein Degradation Pathways: a Link to Neurodegeneration.

Authors:  C Maurel; A Dangoumau; S Marouillat; C Brulard; A Chami; R Hergesheimer; P Corcia; H Blasco; C R Andres; P Vourc'h
Journal:  Mol Neurobiol       Date:  2018-01-10       Impact factor: 5.590

Review 2.  RNA-binding proteins with prion-like domains in health and disease.

Authors:  Alice Ford Harrison; James Shorter
Journal:  Biochem J       Date:  2017-04-07       Impact factor: 3.857

Review 3.  Current and emerging therapeutic targets for Parkinson's disease.

Authors:  Tanvi Pingale; Girdhari Lal Gupta
Journal:  Metab Brain Dis       Date:  2020-10-22       Impact factor: 3.584

4.  Internalization of α-synuclein oligomers into SH-SY5Y cells.

Authors:  Lindsay J Shearer; Nils O Petersen; Michael T Woodside
Journal:  Biophys J       Date:  2021-01-28       Impact factor: 4.033

5.  Quantitative Comparison of HSF1 Activators.

Authors:  Christoph Steurer; Sarah Kerschbaum; Christina Wegrostek; Stefan Gabriel; Ali Hallaj; Viktoria Ortner; Thomas Czerny; Elisabeth Riegel
Journal:  Mol Biotechnol       Date:  2022-02-26       Impact factor: 2.860

Review 6.  The heat shock response in neurons and astroglia and its role in neurodegenerative diseases.

Authors:  Rebecca San Gil; Lezanne Ooi; Justin J Yerbury; Heath Ecroyd
Journal:  Mol Neurodegener       Date:  2017-09-18       Impact factor: 14.195

Review 7.  Possible Function of Molecular Chaperones in Diseases Caused by Propagating Amyloid Aggregates.

Authors:  Vladimir F Lazarev; Elena R Mikhaylova; Irina V Guzhova; Boris A Margulis
Journal:  Front Neurosci       Date:  2017-05-16       Impact factor: 4.677

Review 8.  Protein misfolding in neurodegenerative diseases: implications and strategies.

Authors:  Patrick Sweeney; Hyunsun Park; Marc Baumann; John Dunlop; Judith Frydman; Ron Kopito; Alexander McCampbell; Gabrielle Leblanc; Anjli Venkateswaran; Antti Nurmi; Robert Hodgson
Journal:  Transl Neurodegener       Date:  2017-03-13       Impact factor: 8.014

Review 9.  Chaperone-Based Therapies for Disease Modification in Parkinson's Disease.

Authors:  Erik L Friesen; Mitch L De Snoo; Luckshi Rajendran; Lorraine V Kalia; Suneil K Kalia
Journal:  Parkinsons Dis       Date:  2017-08-21

10.  17-AAG-Induced Activation of the Autophagic Pathway in Leishmania Is Associated with Parasite Death.

Authors:  Antonio Luis de O A Petersen; Benjamin Cull; Beatriz R S Dias; Luana C Palma; Yasmin da S Luz; Juliana P B de Menezes; Jeremy C Mottram; Patrícia S T Veras
Journal:  Microorganisms       Date:  2021-05-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.